ID   KLOT_HUMAN              Reviewed;        1012 AA.
AC   Q9UEF7; Q5VZ95; Q96KV5; Q96KW5; Q9UEI9; Q9Y4F0;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   10-MAY-2017, entry version 138.
DE   RecName: Full=Klotho;
DE            EC=3.2.1.31;
DE   Contains:
DE     RecName: Full=Klotho peptide;
DE   Flags: Precursor;
GN   Name=KL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-45.
RC   TISSUE=Kidney;
RX   PubMed=9363890; DOI=10.1038/36285;
RA   Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T.,
RA   Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A.,
RA   Shiraki-Iida T., Nishikawa S., Nagai R., Nabeshima Y.;
RT   "Mutation of the mouse klotho gene leads to a syndrome resembling
RT   ageing.";
RL   Nature 390:45-51(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), VARIANT
RP   GLN-15, AND TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus, and Kidney;
RX   PubMed=9464267; DOI=10.1006/bbrc.1997.8019;
RA   Matsumura Y., Aizawa H., Shiraki-Iida T., Nagai R., Kuro-o M.,
RA   Nabeshima Y.;
RT   "Identification of the human klotho gene and its two transcripts
RT   encoding membrane and secreted klotho protein.";
RL   Biochem. Biophys. Res. Commun. 242:626-630(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10631108; DOI=10.1006/bbrc.1999.2009;
RA   Kato Y., Arakawa E., Kinoshita S., Shirai A., Furuya A., Yamano K.,
RA   Nakamura K., Iida A., Anazawa H., Koh N., Iwano A., Imura A.,
RA   Fujimori T., Kuro-o M., Hanai N., Takeshige K., Nabeshima Y.;
RT   "Establishment of the anti-Klotho monoclonal antibodies and detection
RT   of Klotho protein in kidneys.";
RL   Biochem. Biophys. Res. Commun. 267:597-602(2000).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=11043382; DOI=10.1007/s001090000131;
RA   Yahata K., Mori K., Arai H., Koide S., Ogawa Y., Mukoyama M.,
RA   Sugawara A., Ozaki S., Tanaka I., Nabeshima Y., Nakao K.;
RT   "Molecular cloning and expression of a novel klotho-related protein.";
RL   J. Mol. Med. 78:389-394(2000).
RN   [6]
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN RENAL FAILURE.
RX   PubMed=11162628; DOI=10.1006/bbrc.2000.4226;
RA   Koh N., Fujimori T., Nishiguchi S., Tamori A., Shiomi S., Nakatani T.,
RA   Sugimura K., Kishimoto T., Kinoshita S., Kuroki T., Nabeshima Y.;
RT   "Severely reduced production of klotho in human chronic renal failure
RT   kidney.";
RL   Biochem. Biophys. Res. Commun. 280:1015-1020(2001).
RN   [7]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15135068; DOI=10.1016/j.febslet.2004.03.090;
RA   Imura A., Iwano A., Tohyama O., Tsuji Y., Nozaki K., Hashimoto N.,
RA   Fujimori T., Nabeshima Y.;
RT   "Secreted Klotho protein in sera and CSF: implication for post-
RT   translational cleavage in release of Klotho protein from cell
RT   membrane.";
RL   FEBS Lett. 565:143-147(2004).
RN   [8]
RP   VARIANTS KL-VS VAL-352 AND SER-370.
RX   PubMed=11792841; DOI=10.1073/pnas.022484299;
RA   Arking D.E., Krebsova A., Macek M. Sr., Macek M. Jr., Arking A.,
RA   Mian I.S., Fried L., Hamosh A., Dey S., McIntosh I., Dietz H.C.;
RT   "Association of human aging with a functional variant of klotho.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:856-861(2002).
RN   [9]
RP   VARIANTS KL-VS VAL-352 AND SER-370.
RX   PubMed=15677572; DOI=10.1161/01.RES.0000157171.04054.30;
RA   Arking D.E., Atzmon G., Arking A., Barzilai N., Dietz H.C.;
RT   "Association between a functional variant of the KLOTHO gene and high-
RT   density lipoprotein cholesterol, blood pressure, stroke, and
RT   longevity.";
RL   Circ. Res. 96:412-418(2005).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-954.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [11]
RP   VARIANT HFTC ARG-193.
RX   PubMed=17710231; DOI=10.1172/JCI31330;
RA   Ichikawa S., Imel E.A., Kreiter M.L., Yu X., Mackenzie D.S.,
RA   Sorenson A.H., Goetz R., Mohammadi M., White K.E., Econs M.J.;
RT   "A homozygous missense mutation in human KLOTHO causes severe tumoral
RT   calcinosis.";
RL   J. Clin. Invest. 117:2684-2691(2007).
CC   -!- FUNCTION: May have weak glycosidase activity towards
CC       glucuronylated steroids. However, it lacks essential active site
CC       Glu residues at positions 239 and 872, suggesting it may be
CC       inactive as a glycosidase in vivo. May be involved in the
CC       regulation of calcium and phosphorus homeostasis by inhibiting the
CC       synthesis of active vitamin D (By similarity). Essential factor
CC       for the specific interaction between FGF23 and FGFR1 (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: The Klotho peptide generated by cleavage of the
CC       membrane-bound isoform may be an anti-aging circulating hormone
CC       which would extend life span by inhibiting insulin/IGF1 signaling.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A beta-D-glucuronoside + H(2)O = D-glucuronate
CC       + an alcohol.
CC   -!- SUBUNIT: Homodimer. Interacts with FGF23 and FGFR1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane
CC       {ECO:0000269|PubMed:10631108, ECO:0000269|PubMed:15135068};
CC       Single-pass type I membrane protein {ECO:0000305}. Apical cell
CC       membrane {ECO:0000250|UniProtKB:O35082}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:O35082}. Note=Isoform 1
CC       shedding leads to a soluble peptide.
CC       {ECO:0000250|UniProtKB:O35082}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted
CC       {ECO:0000269|PubMed:10631108, ECO:0000269|PubMed:15135068}.
CC   -!- SUBCELLULAR LOCATION: Klotho peptide: Secreted
CC       {ECO:0000250|UniProtKB:O35082}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Membrane-bound;
CC         IsoId=Q9UEF7-1; Sequence=Displayed;
CC       Name=2; Synonyms=Secreted;
CC         IsoId=Q9UEF7-2; Sequence=VSP_015824, VSP_015825;
CC         Note=Predominates over the membrane form in all tissues
CC         examined.;
CC   -!- TISSUE SPECIFICITY: Present in cortical renal tubules (at protein
CC       level). Soluble peptide is present in serum and cerebrospinal
CC       fluid. Expressed in kidney, placenta, small intestine and
CC       prostate. Down-regulated in renal cell carcinomas, hepatocellular
CC       carcinomas, and in chronic renal failure kidney.
CC       {ECO:0000269|PubMed:10631108, ECO:0000269|PubMed:11043382,
CC       ECO:0000269|PubMed:11162628, ECO:0000269|PubMed:15135068,
CC       ECO:0000269|PubMed:9464267}.
CC   -!- DOMAIN: Contains 2 glycosyl hydrolase 1 regions. However, the
CC       first region lacks the essential Glu active site residue at
CC       position 239, and the second one lacks the essential Glu active
CC       site residue at position 872.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- POLYMORPHISM: Homozygosity for KL-VS allele is associated with
CC       decreased longevity and increased cardiovascular disease risk.
CC       {ECO:0000269|PubMed:11792841, ECO:0000269|PubMed:15677572}.
CC   -!- DISEASE: Tumoral calcinosis, hyperphosphatemic, familial (HFTC)
CC       [MIM:211900]: A severe metabolic disorder that manifests with
CC       hyperphosphatemia and massive calcium deposits in the skin and
CC       subcutaneous tissues. Some patients manifest recurrent, transient,
CC       painful swellings of the long bones associated with the
CC       radiographic findings of periosteal reaction and cortical
CC       hyperostosis and absence of skin involvement.
CC       {ECO:0000269|PubMed:17710231}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Defects in KL may be a cause of chronic renal
CC       failure complications.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 1 family. Klotho
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The thread of life -
CC       Issue 65 of December 2005;
CC       URL="http://web.expasy.org/spotlight/back_issues/065";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB005142; BAA23382.1; -; mRNA.
DR   EMBL; AB009667; BAA24940.1; -; Genomic_DNA.
DR   EMBL; AB009667; BAA24941.1; -; Genomic_DNA.
DR   EMBL; AL161898; CAH71888.1; -; Genomic_DNA.
DR   EMBL; Z92540; CAC94767.1; -; Genomic_DNA.
DR   EMBL; Z84483; CAC94773.1; -; Genomic_DNA.
DR   CCDS; CCDS9347.1; -. [Q9UEF7-1]
DR   PIR; JC5925; JC5925.
DR   PIR; JC5926; JC5926.
DR   RefSeq; NP_004786.2; NM_004795.3. [Q9UEF7-1]
DR   UniGene; Hs.524953; -.
DR   ProteinModelPortal; Q9UEF7; -.
DR   SMR; Q9UEF7; -.
DR   IntAct; Q9UEF7; 1.
DR   STRING; 9606.ENSP00000369442; -.
DR   CAZy; GH1; Glycoside Hydrolase Family 1.
DR   TCDB; 8.A.49.1.1; the klotho auxiliary protein (klotho) family.
DR   iPTMnet; Q9UEF7; -.
DR   PhosphoSitePlus; Q9UEF7; -.
DR   BioMuta; KL; -.
DR   DMDM; 77416517; -.
DR   PaxDb; Q9UEF7; -.
DR   PeptideAtlas; Q9UEF7; -.
DR   PRIDE; Q9UEF7; -.
DR   Ensembl; ENST00000380099; ENSP00000369442; ENSG00000133116. [Q9UEF7-1]
DR   GeneID; 9365; -.
DR   KEGG; hsa:9365; -.
DR   UCSC; uc001uus.3; human. [Q9UEF7-1]
DR   CTD; 9365; -.
DR   DisGeNET; 9365; -.
DR   GeneCards; KL; -.
DR   H-InvDB; HIX0011224; -.
DR   HGNC; HGNC:6344; KL.
DR   MalaCards; KL; -.
DR   MIM; 211900; phenotype.
DR   MIM; 604824; gene+phenotype.
DR   neXtProt; NX_Q9UEF7; -.
DR   OpenTargets; ENSG00000133116; -.
DR   Orphanet; 306661; Familial tumoral calcinosis.
DR   PharmGKB; PA30130; -.
DR   eggNOG; KOG0626; Eukaryota.
DR   eggNOG; COG2723; LUCA.
DR   GeneTree; ENSGT00550000074452; -.
DR   HOGENOM; HOG000060126; -.
DR   HOVERGEN; HBG081856; -.
DR   InParanoid; Q9UEF7; -.
DR   KO; K14756; -.
DR   OMA; ALSSHWI; -.
DR   OrthoDB; EOG091G0035; -.
DR   PhylomeDB; Q9UEF7; -.
DR   TreeFam; TF314803; -.
DR   Reactome; R-HSA-109704; PI3K Cascade.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-190374; FGFR1c and Klotho ligand binding and activation.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-5654219; Phospholipase C-mediated cascade: FGFR1.
DR   Reactome; R-HSA-5654687; Downstream signaling of activated FGFR1.
DR   Reactome; R-HSA-5654688; SHC-mediated cascade:FGFR1.
DR   Reactome; R-HSA-5654689; PI-3K cascade:FGFR1.
DR   Reactome; R-HSA-5654693; FRS-mediated FGFR1 signaling.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   GeneWiki; Klotho_(biology); -.
DR   GenomeRNAi; 9365; -.
DR   PMAP-CutDB; Q9UEF7; -.
DR   PRO; PR:Q9UEF7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000133116; -.
DR   CleanEx; HS_KL; -.
DR   Genevisible; Q9UEF7; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:Reactome.
DR   GO; GO:0008422; F:beta-glucosidase activity; TAS:ProtInc.
DR   GO; GO:0004566; F:beta-glucuronidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB.
DR   GO; GO:0005104; F:fibroblast growth factor receptor binding; IBA:GO_Central.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW.
DR   GO; GO:0007568; P:aging; IMP:UniProtKB.
DR   GO; GO:0055074; P:calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0006112; P:energy reserve metabolic process; IEA:Ensembl.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:1901657; P:glycosyl compound metabolic process; IBA:GO_Central.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:UniProtKB.
DR   GO; GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
DR   InterPro; IPR001360; Glyco_hydro_1.
DR   InterPro; IPR033132; Glyco_hydro_1_N_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR028546; Klotho.
DR   PANTHER; PTHR10353; PTHR10353; 1.
DR   PANTHER; PTHR10353:SF88; PTHR10353:SF88; 1.
DR   Pfam; PF00232; Glyco_hydro_1; 3.
DR   PRINTS; PR00131; GLHYDRLASE1.
DR   SUPFAM; SSF51445; SSF51445; 2.
DR   PROSITE; PS00653; GLYCOSYL_HYDROL_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Glycoprotein; Glycosidase; Hormone; Hydrolase;
KW   Membrane; Polymorphism; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix; Vitamin D.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34   1012       Klotho.
FT                                /FTId=PRO_0000042243.
FT   CHAIN        34      ?       Klotho peptide. {ECO:0000250}.
FT                                /FTId=PRO_0000042244.
FT   TOPO_DOM     34    981       Extracellular. {ECO:0000255}.
FT   TRANSMEM    982   1002       Helical. {ECO:0000255}.
FT   TOPO_DOM   1003   1012       Cytoplasmic. {ECO:0000255}.
FT   REGION       57    506       Glycosyl hydrolase-1 1.
FT   REGION      515    953       Glycosyl hydrolase-1 2.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    159    159       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    607    607       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    612    612       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    694    694       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     535    549       DTTLSQFTDLNVYLW -> SQLTKPISSLTKPYH (in
FT                                isoform 2). {ECO:0000303|PubMed:9464267}.
FT                                /FTId=VSP_015824.
FT   VAR_SEQ     550   1012       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9464267}.
FT                                /FTId=VSP_015825.
FT   VARIANT      15     15       P -> Q (in dbSNP:rs1052018).
FT                                {ECO:0000269|PubMed:9464267}.
FT                                /FTId=VAR_023582.
FT   VARIANT      45     45       F -> V (in dbSNP:rs1052019).
FT                                {ECO:0000269|PubMed:9363890}.
FT                                /FTId=VAR_023583.
FT   VARIANT     193    193       H -> R (in HFTC; impairs the ability to
FT                                form a ternary complex with FGF23 and
FT                                FGFR1c; impairs KL-dependent FGF23
FT                                signaling; dbSNP:rs121908423).
FT                                {ECO:0000269|PubMed:17710231}.
FT                                /FTId=VAR_064554.
FT   VARIANT     352    352       F -> V (in allele KL-VS; associated with
FT                                S-370; dbSNP:rs9536314).
FT                                {ECO:0000269|PubMed:11792841,
FT                                ECO:0000269|PubMed:15677572}.
FT                                /FTId=VAR_023584.
FT   VARIANT     370    370       C -> S (in allele KL-VS; associated with
FT                                V-352; dbSNP:rs9527025).
FT                                {ECO:0000269|PubMed:11792841,
FT                                ECO:0000269|PubMed:15677572}.
FT                                /FTId=VAR_023585.
FT   VARIANT     514    514       P -> S (in dbSNP:rs3752472).
FT                                /FTId=VAR_049295.
FT   VARIANT     954    954       P -> L (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs139939367).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036449.
SQ   SEQUENCE   1012 AA;  116181 MW;  62031BD73E322E63 CRC64;
     MPASAPPRRP RPPPPSLSLL LVLLGLGGRR LRAEPGDGAQ TWARFSRPPA PEAAGLFQGT
     FPDGFLWAVG SAAYQTEGGW QQHGKGASIW DTFTHHPLAP PGDSRNASLP LGAPSPLQPA
     TGDVASDSYN NVFRDTEALR ELGVTHYRFS ISWARVLPNG SAGVPNREGL RYYRRLLERL
     RELGVQPVVT LYHWDLPQRL QDAYGGWANR ALADHFRDYA ELCFRHFGGQ VKYWITIDNP
     YVVAWHGYAT GRLAPGIRGS PRLGYLVAHN LLLAHAKVWH LYNTSFRPTQ GGQVSIALSS
     HWINPRRMTD HSIKECQKSL DFVLGWFAKP VFIDGDYPES MKNNLSSILP DFTESEKKFI
     KGTADFFALC FGPTLSFQLL DPHMKFRQLE SPNLRQLLSW IDLEFNHPQI FIVENGWFVS
     GTTKRDDAKY MYYLKKFIME TLKAIKLDGV DVIGYTAWSL MDGFEWHRGY SIRRGLFYVD
     FLSQDKMLLP KSSALFYQKL IEKNGFPPLP ENQPLEGTFP CDFAWGVVDN YIQVDTTLSQ
     FTDLNVYLWD VHHSKRLIKV DGVVTKKRKS YCVDFAAIQP QIALLQEMHV THFRFSLDWA
     LILPLGNQSQ VNHTILQYYR CMASELVRVN ITPVVALWQP MAPNQGLPRL LARQGAWENP
     YTALAFAEYA RLCFQELGHH VKLWITMNEP YTRNMTYSAG HNLLKAHALA WHVYNEKFRH
     AQNGKISIAL QADWIEPACP FSQKDKEVAE RVLEFDIGWL AEPIFGSGDY PWVMRDWLNQ
     RNNFLLPYFT EDEKKLIQGT FDFLALSHYT TILVDSEKED PIKYNDYLEV QEMTDITWLN
     SPSQVAVVPW GLRKVLNWLK FKYGDLPMYI ISNGIDDGLH AEDDQLRVYY MQNYINEALK
     AHILDGINLC GYFAYSFNDR TAPRFGLYRY AADQFEPKAS MKHYRKIIDS NGFPGPETLE
     RFCPEEFTVC TECSFFHTRK SLLAFIAFLF FASIISLSLI FYYSKKGRRS YK
//
